Continental Benefits Announces Exclusive Partnership with Regenexx to Reduce Orthopedic Surgical Spend for Employers

Tuesday, March 10, 2020 General News
Email Print This Page Comment bookmark
Font : A-A+

Continental Benefits is excited to announce a unique partnership with Regenexx to offer access to non-surgical orthopedic alternatives to self-funded employer groups

TAMPA, Fla., March 10, 2020 /PRNewswire/ -- Continental Benefits, a full-service Third Party Administrator focused on improving quality of care, has partnered with Regenexx, a network of leading interventional orthopedics clinics. The partnership allows Continental Benefits to offer its clients Regenexx procedures, which can intervene on up to 70% of elective orthopedic injuries where surgery was previously the only solution*.

"Treatment of musculoskeletal conditions is a large and fast growing area of healthcare spend - with the aging of the U.S. population, these costs are becoming a greater burden every year," said Continental Benefits CEO, Betsy Knorr. "I am excited to provide our valued employer groups a high quality, clinically viable alternative to invasive orthopedic surgery."

Regenexx procedures involve precise injections of custom orthobiologics to treat approximately 40 orthopedic conditions. This interventional approach can help employers to reduce the cost of individual procedures by up to 70%, while reducing absenteeism and increasing employee satisfaction, all while decreasing the number of unnecessary orthopedic surgeries performed annually.

"Regenexx is looking forward to expanding our mission of producing the best possible patient outcomes for Continental Benefits and their clients through our innovative alternative to orthopedic surgery," said Regenexx CEO Jason Hellickson. "Overuse and misuse of orthopedic surgery is prevalent in our healthcare system today. Our patented regenerative approach to treating common orthopedic conditions is transforming the care pathway of an orthopedic patient who can now avoid a surgical encounter with less risk and less downtime."

Watch a short video about Regenexx here.

*This applies only to elective orthopedic surgery without fracture-related care and acute care trauma. 

About Continental Benefits

Continental Benefit's mission is to reduce the cost of healthcare while improving quality of care.  Leading the self-funded third party administration (TPA) of healthcare with best-in-class programs allows Continental Benefits to focus on the Triple Aim of healthcare (improving the health of our member population, improving member experience, and reducing health care costs) while emphasizing quality and transparency.

Founded in 2013 and based out of Tampa, Florida, Continental Benefits' focus is on middle to large employer groups, and as a privately owned organization, their attention is on TPA business without distraction from other segments/competing business lines.  For more information, visit www.continentalbenefits.com or call 855.389.7330.

About Regenexx

Regenexx is a nationwide network of physicians who practice Interventional Orthopedics, a new specialty that focuses on using the most advanced regenerative protocols available as an alternative to many orthopedic surgeries. Regenexx has published a significant amount of the research worldwide on the use of orthobiologics for treating orthopedic injuries. Our procedures use your body's natural healing agents including blood platelets and bone marrow concentrate to treat damaged bone, muscle, cartilage, tendons and ligaments. We believe in educating patients, offering options and encouraging people to take an active role in their own treatment. For more information on Regenexx Corporate, visit www.regenexxcorporate.com or call 888.547.6667. For more information on the Regenexx procedures, visit www.regenexx.com.

 

Cision View original content:http://www.prnewswire.com/news-releases/continental-benefits-announces-exclusive-partnership-with-regenexx-to-reduce-orthopedic-surgical-spend-for-employers-301020327.html

SOURCE Regenexx



Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store